Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

CRNX

Rang în acțiuni #2197
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical... Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
Preț acțiune
$84.95
Ultima sincronizare: 2026-09-01
Capitalizare de piață
$9.00B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
110.12%
Țară
US
Tranzacționează Crinetics Pharmaceuticals, Inc. (CRNX)

Categorie

Healthcare
Istoric al prețului acțiunii pentru Crinetics Pharmaceuticals, Inc. (CRNX)
Cel mai mare preț de închidere: $84.95 pe 2026-09-01

Cel mai mic preț de închidere: $24.52 pe 2018-07-01
Istoric al prețului acțiunii pentru Crinetics Pharmaceuticals, Inc. din 2018 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) 3.89%
2025 -13.25%
2024 59.38%
2023 103.03%
2022 -34.46%
2021 91.75%
2020 -37.94%
2019 -30.68%
2018 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$536.91 25.90%
US
$230.20 757.36%
US
$137.83 -3.78%
AU
$892.44 9.61%
NL
$291.76 2.51%
BE